Molina-Molina, M., Kreuter, M., Cottin, V., Corte, T. J., Gilberg, F., Kirchgaessler, K., . . . Maher, T. M. (2022). Efficacy of pirfenidone vs. placebo in unclassifiable interstitial lung disease, by surgical lung biopsy status: Data from a post-hoc analysis. Frontiers in medicine, 9, . https://doi.org/10.3389/fmed.2022.897102
Chicago-Zitierstil (17. Ausg.)Molina-Molina, Maria, Michael Kreuter, Vincent Cottin, Tamera J. Corte, Frank Gilberg, Klaus-Uwe Kirchgaessler, Judit Axmann, und Toby M. Maher. "Efficacy of Pirfenidone Vs. Placebo in Unclassifiable Interstitial Lung Disease, by Surgical Lung Biopsy Status: Data from a Post-hoc Analysis." Frontiers in Medicine 9 (2022). https://doi.org/10.3389/fmed.2022.897102.
MLA-Zitierstil (9. Ausg.)Molina-Molina, Maria, et al. "Efficacy of Pirfenidone Vs. Placebo in Unclassifiable Interstitial Lung Disease, by Surgical Lung Biopsy Status: Data from a Post-hoc Analysis." Frontiers in Medicine, vol. 9, 2022, https://doi.org/10.3389/fmed.2022.897102.